UPC Stock: Universe Pharmaceuticals Inc. Stock Price, Analysis & Insights
Get live UPC stock price $3.37, comprehensive Universe Pharmaceuticals Inc. stock analysis, charts, news, and expert forecast. Real-time UPC stock data and investment insights.
Loading chart data...
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These rem...
Company Information
- CEO
- Gang Lai
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 225
Contact Information
- Address
- No. 265, Jingjiu Avenue
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.60)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Universe Pharmaceuticals Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Universe Pharmaceuticals Inc.
- ⚠Investors should consider how Universe Pharmaceuticals Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
1.90M
P/E Ratio (TTM)
-0.42
Beta
1.60
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare UPC with peer companies:
- Price
- $0.08
- Market cap
- 150.13K
- Price
- $4.50
- Market cap
- 2.04M
- Price
- $1.41
- Market cap
- 2.73M
- Price
- $7.17
- Market cap
- 5.21M
- Price
- $3.17
- Market cap
- 1.43M
- Price
- $0.06
- Market cap
- 7.84M
- Price
- $1.42
- Market cap
- 114.36K
- Price
- $0.45
- Market cap
- 484.52K
- Price
- $0.65
- Market cap
- 698.70K
- Price
- $0.02
- Market cap
- 582.15K
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.